Mettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024. In the quarter to June 2026, revenue grew 4.48%, EPS grew 18.3%, free cash flow grew 33.0% and total debt fell 3.29%, each against the same quarter a year earlier. Member of the S&P 500.
Follow MTD
Mettler-Toledo International, Inc. (MTD) Price to free cash flow
As of 16 October 2026, Mettler-Toledo International, Inc. (MTD) trades at a price to free cash flow of 37.8×. Over the past ten years it has ranged from 22.5× (September 2015) to 50.6× (December 2022); the current reading is higher than 61% of that period. That is above the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 33.9× | 12.92% |
| FY2024 | 30.0× | (2.64%) |
| FY2023 | 30.8× | (30.86%) |
| FY2022 | 44.5× | (8.68%) |
| FY2021 | 48.8× | 13.84% |
| FY2020 | 42.8× | 11.57% |
| FY2019 | 38.4× | 15.91% |
| FY2018 | 33.1× | (17.51%) |
| FY2017 | 40.2× | 20.92% |
| FY2016 | 33.2× | 26.74% |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 29.8× | (7.68%) |
| Mar 2026 | 32.2× | (4.81%) |
| Dec 2025 | 33.9× | 19.73% |
| Sep 2025 | 28.3× | (1.22%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| GH Guardant Health, Inc. compare | n/m |
| DGX Quest Diagnostics Incorporated compare | 19.3× |
| IQV IQVIA Holdings Inc. compare | 19.6× |
| LH Labcorp Holdings Inc. compare | 25.2× |
| IDXX IDEXX Laboratories, Inc. compare | 35.8× |
| MTD Mettler-Toledo International, Inc. | 37.8× |
| A Agilent Technologies, Inc. compare | 38.4× |
| ILMN Illumina, Inc. compare | 43.2× |
| WAT Waters Corporation compare | 117× |
| Diagnostics & Research industry median | 35.8× |
| Healthcare sector median | 20.2× |
| Market median | 14.2× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on MTD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement